European tech funding raised by Switzerland startups during H2 2019.
In H2 2019, 54 startups in Switzerland raised a combined €432M across 54 funding rounds, down 65.7% versus H2 2018. Healthtech was the most active sector, and Swisscom Ventures was the most active investor. Data as of 9 Jul 2026.
5 exits · €331M disclosed.
| Amal Therapeutics | Acquisition | Nov 2019 | €325M |
| id4 | Acquisition | Dec 2019 | €6.4M |
| €37M |
| Coople | Series C | Sep 2019 | €29M |
| cellestia biotech | Series B | Sep 2019 | €18M |
| Swissto12 | Series B | Sep 2019 | €17M |
| teralytics | Series D+ | Sep 2019 | €16M |
| Immunos Therapeutics | Series A | Sep 2019 | €14M |
| BC Platforms | Series C | Sep 2019 | €14M |
| Avrios | Series B | Sep 2019 | €13M |
| Kuros Biosciences | Other | Sep 2019 | €12M |
| Gamaya | Series B | Sep 2019 | €11M |
| Xeltis | Series D+ | Sep 2019 | €11M |
| Carvolution | Series B | Sep 2019 | €10M |